RxDoctor Payments Data

Peter Kurzweil, MD

Orthopedic Surgery · Long Beach, CANPI 1700865466

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $425,863 of the $494,119 with a category attached, or 86.2%. Anika Therapeutics, Inc. accounts for 97.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $428,105 and has fallen 100.0% since, to $15 in 2024. Among orthopedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$494,119in general payments, 2019–2025

Across 91 payments — averaging $5429.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Anika Therapeutics, Inc.$482K
  • Smith+Nephew$10K
  • Dunamis Medical, LLC$510
  • Pacira Therapeutics, Inc.$453
  • Amgen$437
  • Stryker$299
  • plus $354 from 4 others

What the payments were for

  • Consulting fees$2,4751%
  • Speaking & faculty fees$7,7002%
  • Food & beverage$2,3270%
  • Ownership interest$425,86386%
  • Other$55,75411%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$494,119 in reported general payments places this provider in the 95th percentile of 130 orthopedic surgery providers in California.

See all orthopedic surgery providers in California

Medicare billing

Part B allowed, 2024
$981,937
Medicare patients
949
Services billed
21,351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib123$3,764
Meloxicam519$1,351
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen91$1,191
Cephalexin104$568
Diclofenac Sodium25$383
Ibuprofen13$251
Omeprazole64$238
Diclofenac Sodium ErDiclofenac Sodium17$215
Prednisone74$203
Gabapentin18$65
Tramadol Hcl11$33

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →